Both copyright and copyright represent a class of therapies called GLP-One receptor agonists . These powerful substances function by resembling the body's own chemical , GLP-1 , to support reduce blood sugar and encourage weight reduction . This shared mechanism of effect explains why these treatments are frequently evaluated together and represent